Bgm (BGM) Shares Outstanding (2019 - 2026)
Bgm's (BGM) quarterly Shares Outstanding (Entity) came in at $113.3 million in Q3 2025, up 422.44% year-over-year from $21.7 million in Q3 2024, and up 422.44% quarter-over-quarter from $21.7 million in Q3 2024.
Analysis
Bgm (BGM) Shares Outstanding (2019 - 2026) Analysis & Trends
Bgm (BGM) has reported Shares Outstanding (Entity) for 7 consecutive years, with $113.3 million the latest figure, recorded in Q3 2025.
- On a quarterly basis, Shares Outstanding (Entity) rose 422.44% year-over-year to $113.3 million in Q3 2025; TTM through Sep 2025 was $113.3 million, a 422.44% increase from a year earlier, with the FY2025 full-year figure at $113.3 million, up 422.44% from the prior year.
- Shares Outstanding (Entity) was $113.3 million for Q3 2025 at Bgm, up from $21.7 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $113.3 million in Q3 2025 and troughed at $7.2 million in Q3 2021.
- A 5-year average of $34.2 million and a median of $21.7 million in 2023 frame the typical range for Shares Outstanding (Entity).
- Across the five-year window, Shares Outstanding (Entity) changed 0.0% in 2022 and soared 422.44% in 2025, its largest moves.
- Over 5 years, Shares Outstanding (Entity) stood at $7.2 million in 2021, then changed by 0.0% to $7.2 million in 2022, then jumped by 203.21% to $21.7 million in 2023, then changed by 0.0% to $21.7 million in 2024, then soared by 422.44% to $113.3 million in 2025.
- The last three Shares Outstanding (Entity) figures came in at $113.3 million (Q3 2025), $21.7 million (Q3 2024), and $21.7 million (Q3 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.61 Bn | 38.95 Bn | 2.15 Bn | 1.17 Bn |
| 2 | Viatris | 19.14 Bn | 18.25 Bn | 1.46 Bn | 1.16 Bn |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | 832.44 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 319.20 Mn |
| 5 | Bausch Health Companies | 2.38 Bn | 541.37 Mn | 2.10 Bn | 375.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 289.73 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 21.16 Mn |
| 8 | Amphastar Pharmaceuticals | 992.25 Mn | 702.12 Mn | 93.47 Mn | 43.64 Mn |
| 9 | Fennec Pharmaceuticals | 410.57 Mn | 369.32 Mn | 17.15 Mn | 34.55 Mn |
| 10 | Bgm | 31.79 Mn | 20.27 Mn | - | 113.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 113.26 Mn |
| Sep 30, 2025 | 113.26 Mn |
| Mar 31, 2025 | 7.23 Mn |
| Sep 30, 2024 | 7.23 Mn |
| Mar 31, 2024 | 7.15 Mn |
| Sep 30, 2023 | 7.15 Mn |
| Mar 31, 2023 | 7.15 Mn |
| Sep 30, 2022 | 7.15 Mn |
| Mar 31, 2022 | 6.82 Mn |
| Sep 30, 2021 | 6.82 Mn |
| Mar 31, 2021 | 6.00 Mn |
| Sep 30, 2020 | 6.00 Mn |
| Sep 30, 2019 | 6.00 Mn |